Humanised monoclonal antibody therapy for rheumatoid arthritis.
Monoclonal antibodies that target T cells have shown some benefit in rheumatoid arthritis although responses have not been long lasting. This is partly due to insufficient therapy consequent upon antibody immunogenicity. Use of humanised antibodies, which are expected to be less foreign to man than...
Үндсэн зохиолчид: | Isaacs, J, Watts, R, Hazleman, B, Hale, G, Keogan, M, Cobbold, S, Waldmann, H |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1992
|
Ижил төстэй зүйлс
-
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
-н: Isaacs, J, зэрэг
Хэвлэсэн: (1992) -
Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
-н: Isaacs, J, зэрэг
Хэвлэсэн: (2004) -
Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
-н: Isaacs, J, зэрэг
Хэвлэсэн: (2005) -
Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
-н: Isaacs, J, зэрэг
Хэвлэсэн: (2005) -
Humanized monoclonal antibody treatment in rheumatoid arthritis.
-н: Kyle, V, зэрэг
Хэвлэсэн: (1991)